CELLECT BIOTECHNOLOGY LTD.

Company

Quoin Pharmaceuticals, Ltd.

Filed

January 10, 2020

Accession Number

0000902664-20-000160

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →